• KOL
    • KOLs Community
    • Eosinophilic
    • Eosinophilic Granulomatosis
    • David Jayne
    • David Jayne

      David Jayne

      Leeds Institute of Medical Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK | The John Goligher Colorectal Surgery Unit, St. James's University ...

       

       

      KOL Resume for David Jayne

      Year
      2022

      Leeds Institute of Medical Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK

      University of Cambridge

      for the TESTING Study Group

      2021

      Division of Nephrology, Department of Medicine, University of Cambridge, Cambridge, UK

      2020

      Medicine, University of Cambridge, Cambridge, UK

      University of CAMBRIDGE

      Europian Vasculitis Society

      2019

      University of Cambridge Addenbrookes Hospital Cambridge, United Kingdom

      United States Navy, Gulfport, MS, USA

      2016

      Dept of Medicine, University of Cambridge, UK

      2015

      University of Cambridge, Department of Medicine, Cambridge, UK.

      2013

      Addenbrooke's Hospital Lupus and Vasculitis Clinic CUHNHSFT, Cambridge UK

      2009

      Chief, Division of Nephrology and Hypertension University of North Carolina Chapel Hill, North Carolina

      Professor of Medicine, University of Utah and Veternas Affairs, Salt Lake City Healthcare System

      DJ Thurston Professsor O Medicine Director, UNC Kidney Center

      2007

      UTC Power

      2005

      Chemical Engineering Department, Environmental Engineering Program, University of Connecticut, Storrs, CT 06269, USA

      1999

      Australian Bureau of Statistics, 313 Adelaide Street Brisbane, QLD, 4000

       

       

      David Jayne: Influence Statistics

      Sample of concepts for which David Jayne is among the top experts in the world.
      Concept World rank
      vasculitis plasma exchange #5
      cardiovascular p120 #7
      patient cmavm #8
      report cmavm #8
      financial therapists #13
      mutation rasgap #20
      archuleta #21
      – avm #21
      development egpa #22
      financial anxiety #22
      – arteriovenous #37
      years egpa #48
      patients definite vasculitis #48
      rasgap domain #49
      criteria egpa #49
      cases egpa #55
      anca testing patients #55
      malformation – #61
      consensus anca #64
      financial therapy #66
      egpa asthma #71
      manifestations eosinophilic #72
      rasa1 mutation #73
      diagnosis egpa #75
      polyangiitis eosinophilic granulomatosis #79
      polyangiitis hepatitis #80
      egpa diagnosis #82
      patients polyangiitis #82
      diesel adsorption #86
      vasculitis eosinophilic #86
      vasculitis features #86
      anca tested #86
      management pmr #90
      study egpa #96
      definite vasculitis #96
      polyangiitis churgstrauss #97

       

      Prominent publications by David Jayne

      KOL-Index: 12381

      OBJECTIVES: The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) have been validated with high sensitivity and specificity. We evaluated the performance of the new criteria with regard to disease duration, sex and race/ethnicity, and compared its performance against the Systemic Lupus International Collaborating Clinics (SLICC) 2012 and ACR 1982/1997 criteria.

      METHODS: Twenty-one SLE ...

      Known for Early Disease | Acr Criteria | Sensitivity Specificity | Systemic Lupus | 2019 Eular
      KOL-Index: 10735

      OBJECTIVE: To guide nosology and classification of patients with eosinophilic granulomatosis with polyangiitis (EGPA) based on phenotype and presence or absence of ANCA.

      METHODS: Organ manifestations and ANCA status were retrospectively analyzed based on the presence or not of predefined definite vasculitis features or surrogates of vasculitis in patients asthma, eosinophilia, and at least one systemic organ manifestation attributable to systemic disease.

      RESULTS: The study population ...

      Known for Systemic Vasculitis | Eosinophilic Granulomatosis | Anca Patients | Polyangiitis Egpa | Mononeuritis Multiplex
      KOL-Index: 9130

      This document follows up on a 2017 revised international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic polyangiitis and focuses on the clinical and diagnostic value of ANCA detection in patients with connective tissue diseases, idiopathic interstitial pneumonia, autoimmune liver diseases, inflammatory bowel diseases, anti-glomerular basement membrane (GBM) disease, infections, malignancy, and during drug treatment. ...

      Known for Anca Testing | International Consensus | Autoimmune Liver Diseases | Infective Endocarditis | Ulcerative Colitis
      KOL-Index: 7838

      BACKGROUND/OBJECTIVES: The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria for systemic lupus erythematosus system showed high specificity, while attaining also high sensitivity. We hereby analysed the performance of the individual criteria items and their contribution to the overall performance of the criteria.

      METHODS: We combined the EULAR/ACR derivation and validation cohorts for a total of 1197 systemic lupus ...

      Known for European League | Classification Criteria | Sensitivity Performance | Rheumatology Acr | Attribution Rule
      KOL-Index: 7305

      The respiratory manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) have not been studied in detail.In this retrospective multicentre study, EGPA was defined by asthma, eosinophilia and at least one new onset extra-bronchopulmonary organ manifestation of disease.The study population included 157 patients (mean±sd age 49.4±14.1 years), with a mean±sd blood eosinophil count of 7.4±6.4×109 L-1 at diagnosis. There was a mean±sd of 11.8±18.2 years from the onset of asthma ...

      Known for Eosinophilic Granulomatosis | Egpa Asthma | Polyangiitis Humans | Patients Diagnosis | 3 Years
      KOL-Index: 6915

      Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology as a framework for the project. Accordingly, the direction and strength of the ...

      Known for Polymyalgia Rheumatica | Patients Pmr | European League | Recommendations Management | Glucocorticoids Humans
      KOL-Index: 6671

      Carbon aerogels (CAs) were investigated as adsorbents for the desulfurization of liquid hydrocarbon fuels for fuel cell applications. Synthetic mixtures of dibenzothiophene (DBT) and 4,6-dimethyldibenzothiophene (4,6-DMDBT) in n-hexadecane (n-HD) were used as models for sulfur contaminated diesel fuel. Carbon aerogels were found to have good adsorption capacity for both DBT and 4,6-DMDBT. Both the thermodynamics and dynamics of adsorption were investigated by the measurement of ...

      Known for Fuel Cell Applications | Adsorption Dbt | Carbon Aerogels | Organosulfur Compounds | Pore Size
      KOL-Index: 6403

      Capillary malformation-arteriovenous malformation (CM-AVM) is a newly recognized clinical entity caused by mutation of the RASA1 gene, which encodes p120-RasGAP. Here we describe, for the first time, a patient with CM-AVM presenting during the late stages of pregnancy with pulmonary "capillary level" microvascular shunt, worsening cutaneous capillary malformations, and gross fluid overload. Sequencing revealed a novel mutation of the RASA1 gene involving a frameshift mutation in the ...

      Known for Rasa1 Mutation | Capillary Malformation | Rasgap Domain | Report Cmavm | Avm Pregnancy
      KOL-Index: 4882

      OBJECTIVE: To achieve consensus on a definition of remission in SLE (DORIS).

      BACKGROUND: Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.

      METHODS: Several systematic literature reviews were performed and specific research questions ...

      Known for Remission Sle | Task Force | Lupus Erythematosus | Global Assessment
      KOL-Index: 3349

      Financial anxiety appears to have a significant effect on the lives of many Americans (APA Stress in America™, paying with our health, American Psychological Association, Washington, DC, 2015) and a source of client distress among mental health clinicians, financial professionals, and financial therapists. Solution-Focused Brief Therapy (SFBT) has been utilized in number disciplines as a way to help professionals interact with clients to create change and improve well-being. This study ...

      Known for Financial Anxiety | Mental Health Clinicians | Focused Therapy | Study Utilized
      KOL-Index: 3021

      OBJECTIVE: To develop and validate revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA).

      METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate criteria items using consensus methodology, 2) prospective collection of candidate items present at the time of diagnosis, 3) data-driven reduction of the number of candidate items, 4) expert panel ...

      Known for Eosinophilic Granulomatosis | Classification Criteria | Polyangiitis Egpa | Cytoplasmic Antibody | Vessel Vasculitis
      KOL-Index: 2503

      OBJECTIVE: To assess the efficacy and safety of the type I interferon receptor antibody, anifrolumab, in patients with active, biopsy-proven, Class III/IV lupus nephritis.

      METHODS: This phase II double-blinded study randomised 147 patients (1:1:1) to receive monthly intravenous anifrolumab basic regimen (BR, 300 mg), intensified regimen (IR, 900 mg ×3, 300 mg thereafter) or placebo, alongside standard therapy (oral glucocorticoids, mycophenolate mofetil). The primary endpoint was change ...

      Known for Lupus Nephritis | Mycophenolate Mofetil | Patients Active | Type Interferon | Herpes Zoster
      KOL-Index: 2256

      OBJECTIVE: To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA).

      METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate criteria items using consensus methodology, 2) prospective collection of candidate items present at the time of diagnosis, 3) data-driven reduction of the number of candidate items, 4) expert panel review of cases ...

      Known for Classification Criteria | Granulomatosis Polyangiitis | Cytoplasmic Antibody | Small Medium | Vessel Vasculitis
      KOL-Index: 1946

      OBJECTIVE: To develop and validate classification criteria for microscopic polyangiitis (MPA).

      METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items using consensus methodology, 2) prospective collection of candidate items present at the time of diagnosis, 3) data-driven reduction of the number of candidate items, 4) expert panel review of cases to define the reference ...

      Known for Microscopic Polyangiitis | Classification Criteria | Cytoplasmic Antibody | Vessel Vasculitis | Small Medium

      Key People For Eosinophilic Granulomatosis

      Top KOLs in the world
      #1
      Loic P Guillevin
      polyarteritis nodosa plasma exchange systemic sclerosis
      #2
      Alfred Daniel Mahr
      plasma exchange giant cell arteritis microscopic polyangiitis
      #3
      Christian Pagnoux
      central nervous takayasu arteritis microscopic polyangiitis
      #4
      Luc Mouthon
      systemic sclerosis ssc patients microscopic polyangiitis
      #5
      David R W Jayne
      systemic vasculitis lupus nephritis plasma exchange
      #6
      Pascal Cohen
      polyarteritis nodosa microscopic polyangiitis strauss syndrome

      David Jayne:Expert Impact

      Concepts for whichDavid Jaynehas direct influence:Eosinophilic granulomatosis,  Systemic vasculitis,  Plasma exchange,  Financial anxiety,  European league,  Systemic lupus erythematosus,  Patients aav,  Classification criteria.

      David Jayne:KOL impact

      Concepts related to the work of other authors for whichfor which David Jayne has influence:Eosinophilic granulomatosis,  Polymyalgia rheumatica,  Systemic lupus erythematosus,  Carbon xerogels,  Polyangiitis egpa,  Giant cell arteritis,  Classification criteria.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Leeds Institute of Medical Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK | The John Goligher Colorectal Surgery Unit, St. James's University Hospital, Leeds, UK | University of Cambridge | Department of Medicine, University

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.